| Literature DB >> 26700278 |
Guohua Zheng1, Xin Zheng1, Junzhe Li1, Tingjin Duan2, Dalu Qi2, Kun Ling2, Jian He1, Lidian Chen3.
Abstract
INTRODUCTION: Controlling risk factors with regular exercise is effective and cost-effective for the primary prevention of ischaemic stroke. As a traditional Chinese form of exercise, Tai Chi might be beneficial in decreasing ischaemic stroke, but the evidence remains insufficient. We hypothesise that elderly community adults with risk factors for ischaemic stroke will decrease their ischaemic stroke risk by improving cerebral haemodynamic parameters, cardiopulmonary function, motor function, plasma risk indices, physical parameters or psychological outcomes after receiving 12 weeks of regular Tai Chi training compared with those who maintained their original physical activities. Therefore, we designed a randomised controlled trial that will systematically evaluate the protective effects of Tai Chi exercise on ischaemic stroke risk in an elderly community population with risk factors for ischaemic stroke. METHODS AND ANALYSIS: A total of 170 eligible participants were randomly allocated into either the Tai Chi training group or the usual physical activity group. This paper reports on the design, intervention development and baseline characteristics of the participants. There were no significant differences between comparison groups in demographic characteristics or the baseline data of primary or secondary outcomes. Participants in the Tai Chi training group will receive 12 weeks of Tai Chi training with a frequency of 5 days/week and 60 min/day, while those in the usual physical activities group will maintain their original activities. Primary and secondary outcomes will be measured at the 12-week and 24-week follow-ups. ETHICS AND DISSEMINATION: Ethical approval has been obtained from the Medical Ethics Committee of The Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine (number 2013-020-02). The findings of this study will be communicated to healthcare professionals, participants and the public through peer-reviewed publications or scientific conferences. TRIAL REGISTRATION NUMBER: ChiCTR-TRC-13003601; Pre-results. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/Entities:
Keywords: PREVENTIVE MEDICINE; SPORTS MEDICINE; STROKE MEDICINE
Mesh:
Year: 2015 PMID: 26700278 PMCID: PMC4691734 DOI: 10.1136/bmjopen-2015-009158
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Specification of 24 forms of simplified Tai Chi Chuan.
Brief description of outcome assessments
| Recruitment | Post-training | Post follow-up | |
|---|---|---|---|
| Items | -2-(-1) weeks | 12-week | 24-week |
| Demographic characteristics | |||
| Cerebral haemodynamic parameters | |||
| Cardiopulmonary function | |||
| Cardiac structure and function | |||
| Resting pulmonary function | |||
| Plasma risk indicators of cardiovascular disease | |||
| Blood lipid | |||
| Fasting blood glucose | |||
| Homocysteine | |||
| Motor capability | |||
| Balance function | |||
| Lower limbs proprioception function | |||
| Physical parameters | |||
| Body mass index | |||
| Waist-to-hip ratio | |||
| 6 min walk test | |||
| Sit-and-reach | |||
| Time for one foot standing with eyes closed | |||
| Psychological outcomes | |||
| Health-related quality of life | |||
| Quality of sleep | |||
| Mood | |||
| Safety assessments | |||
Figure 2Flow chart of participants’ recruitment and trial design.
Baseline demographic characteristics of participants between Tai Chi group and control group
| Variable | Tai Chi group | Usual physical activity group | T value (χ2) | p Value |
|---|---|---|---|---|
| Age, years (mean±SD) | 61.01±5.20 | 60.73±6.05 | 0.326 | 0.744 |
| Seated systolic BP, mm Hg (mean±SD) | 133.81±16.74 | 129.04±15.94 | 1.906 | 0.058 |
| Seated diastolic BP, mm Hg (mean±SD) | 77.74±9.28 | 76.35±10.48 | 0.914 | 0.362 |
| Height, cm (mean±SD) | 160.41±7.42 | 159.70±7.46 | 0.622 | 0.534 |
| Body weight, kg (mean±SD) | 65.312±9.53 | 64.14±10.90 | 0.744 | 0.458 |
| Average daily activity time, h (median, 25–75%) | 4.429 (6.964–2.071) | 4.857 (6.892–2.857) | −0.577 | 0.564 |
| Gender (n, %) | ||||
| Male | 28 (32.9) | 24 (28.2) | 0.443 | 0.506 |
| Female | 57 (67.1) | 61 (71.8) | ||
| Nationality (n, %) | ||||
| Han nationality | 84 (99.8) | 85 (100) | 1.006 | 0.316 |
| Minority nationality | 1 (0.2) | 0 (0) | ||
| Marital (n, %) | ||||
| Married | 79 (92.9) | 80 (94.1) | 1.406 | 0.495 |
| Widowed | 6 (7.1) | 4 (4.7) | ||
| Divorced | 0 (0) | 1 (1.2) | ||
| Lever of education (n, %) | ||||
| Primary school | 11 (12.9) | 19 (22.4) | 7.681 | 0.053 |
| Junior high school | 33 (38.8) | 18 (21.2) | ||
| Senior high school | 25 (29.5) | 33 (38.8) | ||
| High school or above | 16 (18.8) | 15 (17.6) | ||
| History of heart disease (n, %) | ||||
| Yes | 9 (10.6) | 14 (16.5) | 1.257 | 0.262 |
| No | 76 (89.4) | 71 (83.5) | ||
| History of diabetes (n, %) | ||||
| Yes | 8 (9.4) | 11 (12.9) | 0.533 | 0.465 |
| No | 77 (90.6) | 74 (87.1) | ||
| History of hypertension (n, %) | ||||
| Yes | 39 (45.9) | 38 (44.7) | 0.024 | 0.878 |
| No | 46 (54.1) | 47 (55.3) | ||
| History of dyslipidaemia (n, %) | ||||
| Yes | 50 (58.8) | 53 (62.4) | 0.222 | 0.638 |
| No | 35 (41.2) | 32 (37.6) | ||
| Family history of stroke (n, %) | ||||
| Yes | 16 (18.8) | 15 (17.7) | 0.039 | 0.843 |
| No | 69 (81.2) | 70 (82.3) | ||
| Smoking (n, %) | ||||
| Yes | 11 (12.9) | 15 (17.7) | 0.726 | 0.394 |
| No | 74 (87.1) | 70 (82.3) | ||
| Drinking (n, %) | ||||
| Yes | 23 (27.1) | 28 (32.9) | 0.700 | 0.403 |
| No | 62 (72.9) | 57 (67.1) | ||
BP, blood pressure.
Baseline cerebral haemodynamic parameters between Tai Chi group and usual physical activities group
| Variables | Tai Chi group | Usual physical activity group | T value/Z value/χ2 value | p Value | ||
|---|---|---|---|---|---|---|
| n | Mean±SD (Median, 25%–75%) | n | Mean±SD (Median, 25%–75%) | |||
| Basilar artery | ||||||
| Vmax, cm/s | 82 | 65.89±17.62 | 85 | 62.84±16.57 | 1.155 | 0.250 |
| Vmin, cm/s | 82 | 59.34±16.55 | 85 | 56.71±15.42 | 1.065 | 0.288 |
| Vmean, cm/s | 82 | 62.57±16.75 | 85 | 59.91±15.98 | 1.053 | 0.294 |
| PI | 82 | 0.92±0.19 | 85 | 0.95±0.25 | −0.902 | 0.368 |
| RI | 82 | 0.57±0.07 | 85 | 0.58±0.09 | −0.593 | 0.554 |
| Missing* | 3 | 0 | 0.246 | |||
| Left vertebral artery | ||||||
| Vmax, cm/s | 82 | 59.0 (68.25–46.0) | 85 | 56.0 (69.0–45.5) | −0.463 | 0.644 |
| Vmin, cm/s | 82 | 52.0 (59.75–40.0) | 85 | 49.0 (60.0–39.0) | −0.608 | 0.543 |
| Vmean, cm/s | 82 | 56.0 (63.50–43.0) | 85 | 52.0 (66.0–41.5) | −0.453 | 0.650 |
| PI | 82 | 0.91±0.19 | 85 | 0.94±0.21 | −1.223 | 0.223 |
| RI | 82 | 0.56±0.07 | 85 | 0.57±0.08 | −1.291 | 0.198 |
| Missing* | 3 | 0 | 0.246 | |||
| Right vertebral artery | ||||||
| Vmax, cm/s | 82 | 59.32±16.95 | 82 | 58.13±16.12 | 0.458 | 0.648 |
| Vmin, cm/s | 82 | 52.37±15.51 | 82 | 51.06±14.65 | 0.554 | 0.580 |
| Vmean, cm/s | 82 | 55.73±16.12 | 82 | 54.72±15.26 | 0.413 | 0.680 |
| PI | 82 | 0.93±0.20 | 82 | 0.97±0.19 | −1.346 | 0.180 |
| RI | 82 | 0.57±0.07 | 82 | 0.58±0.07 | −1.348 | 0.180 |
| Missing | 3 | 3 | 0 | 1.0 | ||
| Left anterior cerebral artery | ||||||
| Vmax, cm/s | 60 | 80.57±20.17 | 69 | 82.78±18.73 | −0.647 | 0.519 |
| Vmin, cm/s | 60 | 71.5 (81.75–60.0) | 69 | 76.00 (89.00–58.50) | 1.037 | 0.300 |
| Vmean, cm/s | 60 | 75.0 (84.75–64.0) | 69 | 78.00 (92.50–64.50) | −1.013 | 0.311 |
| PI | 60 | 0.86±0.17 | 69 | 0.90±0.20 | −1.397 | 0.165 |
| RI | 60 | 0.54±0.07 | 69 | 0.56±0.08 | −1.283 | 0.202 |
| Missing | 25 | 16 | 2.604 | 0.107 | ||
| Right anterior cerebral artery | ||||||
| Vmax, cm/s | 55 | 80.0 (95.00–64.0) | 55 | 77.0 (94.0–68.0) | −0.006 | 0.995 |
| Vmin, cm/s | 55 | 73.49±20.53 | 55 | 72.44±19.66 | 0.275 | 0.784 |
| Vmean, cm/s | 55 | 77.38±21.00 | 55 | 76.04±19.53 | 0.348 | 0.729 |
| PI | 55 | 0.85±0.15 | 55 | 0.90±0.20 | −1.472 | 0.144 |
| RI | 55 | 0.54±0.06 | 55 | 0.56±0.08 | −1.859 | 0.066 |
| Missing | 30 | 30 | 0 | 1.0 | ||
| Left middle cerebral artery | ||||||
| Vmax, cm/s | 60 | 93.27±21.59 | 71 | 94.65±21.65 | −0.364 | 0.716 |
| Vmin, cm/s | 60 | 85.37±20.87 | 71 | 87.58±21.00 | −0.603 | 0.548 |
| Vmean, cm/s | 60 | 89.08±20.72 | 71 | 90.72±21.26 | −0.444 | 0.658 |
| PI | 60 | 0.88±0.15 | 71 | 0.92±0.19 | −1.199 | 0.233 |
| RI | 60 | 0.55±0.06 | 71 | 0.57±0.07 | −1.199 | 0.265 |
| Missing | 25 | 14 | 4.026 | 0.045 | ||
| Right middle cerebral artery | ||||||
| Vmax, cm/s | 55 | 90.95±24.31 | 63 | 96.38±21.15 | −1.299 | 0.197 |
| Vmin, cm/s | 55 | 83.44±23.29 | 63 | 87.79±20.75 | −1.075 | 0.285 |
| Vmean, cm/s | 55 | 87.71±24.07 | 63 | 91.79±21.03 | −0.984 | 0.327 |
| PI | 55 | 0.87±0.13 | 63 | 0.88±0.16 | −0.486 | 0.628 |
| RI | 55 | 0.55±0.07 | 63 | 0.55±0.06 | −0.257 | 0.797 |
| Missing | 30 | 22 | 1.773 | 0.183 | ||
| Left posterior cerebral artery | ||||||
| Vmax, cm/s | 61 | 51.26±9.87 | 68 | 53.31±11.92 | −0.869 | 0.387 |
| Vmin, cm/s | 61 | 46.26±9.01 | 68 | 47.21±11.13 | −0.525 | 0.600 |
| Vmean, cm/s | 61 | 49.00±9.41 | 68 | 50.12±11.46 | −0.601 | 0.549 |
| PI | 61 | 0.91±0.15 | 68 | 0.93±0.19 | −0.622 | 0.535 |
| RI | 61 | 0.56±0.06 | 68 | 0.57±0.07 | −0.558 | 0.578 |
| Missing | 24 | 17 | 1.575 | 0.209 | ||
| Right posterior cerebral artery | ||||||
| Vmax, cm/s | 57 | 51.07±11.21 | 54 | 50.89±10.73 | 0.087 | 0.931 |
| Vmin, cm/s | 57 | 44.46±9.80 | 54 | 44.87±9.43 | −0.227 | 0.821 |
| Vmean, cm/s | 57 | 47.72±10.27 | 54 | 48.15±10.20 | −0.221 | 0.826 |
| PI | 57 | 0.88±0.16 | 54 | 0.92±0.17 | −1.117 | 0.267 |
| RI | 57 | 0.55±0.06 | 54 | 0.56±0.07 | −1.010 | 0.315 |
| Missing | 28 | 31 | 0.234 | 0.629 | ||
Missing*, Fisher's exact test; Missing, Pearson's χ2 test; PI, pulsatility index; RI, resistance index; Vmax, maximum blood flow velocity; Vmean, mean blood flow velocity; Vmin, minimum blood flow velocity.
Baseline comparison of secondary outcomes between Tai Chi and usual physical activities group
| Variables | Tai Chi group | Usual physical activity group | T(Z) value | p Value | ||
|---|---|---|---|---|---|---|
| n | Mean±SD (median, 75–25%) | n | Mean±SD (median, 75–25%) | |||
| Cardiac structure and function | ||||||
| AOD, cm | 85 | 2.73±0.32 | 85 | 2.77±0.34 | −0.748 | 0.456 |
| LAD, cm | 85 | 3.17±0.46 | 85 | 3.18±0.52 | −0.158 | 0.874 |
| IVST, cm | 85 | 1.03±0.14 | 85 | 1.02±0.15 | 0.477 | 0.634 |
| LVDD, cm | 85 | 4.38±0.51 | 85 | 4.38±0.40 | 0.050 | 0.960 |
| LVPWT, cm | 85 | 0.94±0.11 | 85 | 0.93±0.11 | 0.707 | 0.480 |
| LVAWT, cm | 85 | 1.03±0.12 | 85 | 1.03±0.13 | −0.176 | 0.861 |
| RAD, cm | 85 | 3.14 (3.34–2.95) | 85 | 3.06 (3.32–2.85) | −1.052 | 0.293 |
| RVID, cm | 85 | 2.96±0.35 | 85 | 2.97±0.35 | −0.307 | 0.759 |
| MPAD, cm | 85 | 2.05±0.20 | 85 | 2.09±0.27 | −1.106 | 0.270 |
| LVEF, % | 85 | 62.0 (65.5–58.5) | 85 | 63.0 (65.0–60.0) | −0.866 | 0.387 |
| Static lung function | ||||||
| VCmax, L | 83 | 2.97±0.69 | 82 | 2.86±0.70 | 1.074 | 0.285 |
| FEV1, L | 83 | 2.40±0.55 | 82 | 2.31±0.59 | 1.018 | 0.310 |
| FEV1%FVC | 83 | 88.18 (91.65–83.50) | 82 | 87.51 (92.39–83.69) | −0.018 | 0.986 |
| MVV, L/min | 83 | 78.96 (100.34–66.74) | 82 | 86.03 (107.0–72.2) | −1.142 | 0.253 |
| Missing | 2 | 3 | ||||
| Plasma risk factor indexes | ||||||
| TC, mmol/L | 85 | 5.58±1.05 | 85 | 5.52±1.17 | 0.357 | 0.772 |
| TG, mmol/L | 85 | 1.30 (1.73–0.95) | 85 | 1.23 (1.65–0.98) | −0.168 | 0.866 |
| LDL, mmol/L | 85 | 3.62±0.90 | 85 | 3.76±1.09 | −0.931 | 0.353 |
| HDL, mmol/L | 85 | 1.34 (1.62–1.15) | 85 | 1.27 (1.51–1.08) | −1.298 | 0.194 |
| FBG, mmol/L | 85 | 5.41 (5.82–5.06) | 85 | 5.37 (6.06–5.09) | −0.323 | 0.747 |
| HCY, μmol/L | 85 | 10.80 (12.80–8.42) | 85 | 9.82 (12.70–8.25) | −1.085 | 0.278 |
| Balance capability | ||||||
| Opened eyes perimeter, mm | 85 | 278.0 (347.0–233.5) | 85 | 267.0 (322.5–213.5) | −1.220 | 0.222 |
| Closed eyes perimeter, mm | 85 | 480.0 (594.0–359.0) | 85 | 418.0 (563.0–346.5) | −1.577 | 0.115 |
| Opened eyes ellipse area, mm2 | 85 | 228.0 (324.5–167.0) | 85 | 241.0 (362.0–160.0) | −0.249 | 0.803 |
| Closed eyes ellipse area, mm2 | 85 | 494.0 (768.0–344.0) | 85 | 533.0 (722.0–354.0) | −0.185 | 0.853 |
| Proprioception capability | ||||||
| ATE of right lower limb | 85 | 39.0 (58.5–31.5) | 85 | 39.0 (58.5–31.5) | −0.708 | 0.479 |
| ATE of left lower limb | 85 | 36.0 (49.0–28.5) | 85 | 39.0 (56.0–27.5) | −0.874 | 0.382 |
| ATE of waist clockwise | 85 | 48.0 (79.0–34.5) | 85 | 53.0 (68.0–37.0) | −0.031 | 0.975 |
| ATE of waist anticlockwise | 85 | 46.0 (63.5–33.5) | 85 | 45.0 (60.5–35.0) | −0.067 | 0.947 |
| Physical parameters | ||||||
| BMI, kg/m2 | 85 | 25.37±3.19 | 85 | 25.04±3.05 | 0.686 | 0.494 |
| WHR | 85 | 0.90±0.07 | 85 | 0.90±0.07 | 0.351 | 0.726 |
| Flexibility, cm | 85 | −2.67±11.32 | 85 | −3.60±12.37 | 0.513 | 0.609 |
| Psychological outcomes | ||||||
| SF-36 scales | ||||||
| SF-36 (PCS) | 85 | 81.00 (87.88–66.75) | 85 | 72.50 (83.25–56.50) | −2.763 | 0.006 |
| SF-36(MCS) | 85 | 85.25 (92.00–72.96) | 85 | 81.75 (90.75–65.52) | −1.694 | 0.090 |
| Quality of sleep (PSQI) | 85 | 6.0 (9.0–4.0) | 85 | 6.0 (9.0–4.0) | −0.642 | 0.521 |
| Mood, (POMS-SF) | 85 | 93.0 (106.0–82.0) | 85 | 94.0 (115.0–80.5) | −0.165 | 0.869 |
AOD, aortic diameter; ATE, average track error; BMI, body mass index; FBG, fasting blood glucose; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; HCY, homocysteine; HDL, high-density lipoprotein; IVST, interventricular septum thickness; LAD, left atrial diameter; LDL, low-density lipoprotein; LVAWT, left ventricular anterior wall thickness; LVDD, left ventricular diastolic diameter; LVEF, left ventricular ejection fraction; LVPWT, left ventricular posterior wall thickness; MCS, mental component summary score; MPAD, main pulmonary artery diameter; MVV, maximal voluntary ventilation; PCS, physical component summary score; POMS-SF, Profile of Mood States Short Form; PSQI, Pittsburgh Sleep Quality Index; RAD, right atrial diameter; RVID, right ventricle internal diameter; TC, total cholesterol; TG, triglyceride; VCmax, maximum vital capacity; WHR, waist-to-hip ratio.